SCHEMBL7022004

SCHEMBL7022004

CC(S)(CS)CCn1c(=O)[nH]c2cccnc2c1=O

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ADRA1B P35368 1/20 0.42
ADORA3 P0DMS8 3/20 0.42
ADORA1 P30542 3/20 0.42
ADORA2A P29274 2/20 0.42
DAO P14920 1/20 0.35
PARP1 P09874 1/20 0.35
CYP1A2 P05177 1/20 0.35
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
MPO P05164 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ADORA2B P29275 1/20 0.34
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7022008 1.00 ADRA1B (0.42) ADRA1BADORA3ADORA1ADORA2ADAO
SCHEMBL7022190 0.88 ADORA3 (0.41) ADRA1BADORA3ADORA1ADORA2ADAO
SCHEMBL7014576 0.88 ADORA3 (0.41) ADRA1BADORA3ADORA1ADORA2ADAO
SCHEMBL7017940 0.81 KDM4E (0.41) ADRA1BADORA3ADORA2AALDH1A1HPGD
SCHEMBL7017938 0.81 KDM4E (0.41) ADRA1BADORA3ADORA2AALDH1A1HPGD
SCHEMBL7014430 0.81 MAPT (0.48) ADRA1BPARP1CYP1A2ALDH1A1KDM4E
SCHEMBL7014427 0.81 MAPT (0.48) ADRA1BPARP1CYP1A2ALDH1A1KDM4E
SCHEMBL30970867 0.79 ADORA3 (0.62) ADRA1BADORA3ADORA1ADORA2ADAO
SCHEMBL11868273 0.77 ADORA3 (0.53) ADRA1BADORA3ADORA1ADORA2AALDH1A1
SCHEMBL7019512 0.76 ADRA1B (0.43) ADRA1BADORA3ADORA1ADORA2ADAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003089416-A1 SUBSTITUTED PYRIMIDINE-2,4(1H,3H)-DIONES FOR USE AS MATRIX METALLOPROTEINASE (MMP) INHIBITORS IBFB GMBH (DE) 2003-10-30 WO disclosed
EP-1357114-A1 Substituted pyrimidin-2,4(1H,3H)-diones as inhibitors of Matrix Metalloproteinases (MMP) IBFB GmbH Privates Institut für biomedizinische Forschung und Beratung (DE) 2003-10-29 EP disclosed